TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

John M Kirkwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.